BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34587154)

  • 1. Suppressor effect of catechol-O-methyltransferase gene in prostate cancer.
    Hashimoto Y; Shiina M; Maekawa S; Kato T; Shahryari V; Kulkarni P; Dasgupta P; Yamamura S; Saini S; Tabatabai ZL; Dahiya R; Tanaka Y
    PLoS One; 2021; 16(9):e0253877. PubMed ID: 34587154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
    Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
    Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
    Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
    Du C; Lv C; Feng Y; Yu S
    J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer.
    Li T; Xing Y; Yang F; Sun Y; Zhang S; Wang Q; Zhang W
    Cancer Med; 2020 Jun; 9(11):3852-3862. PubMed ID: 32248648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
    Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1.
    Wang S; Qiu J; Wang L; Wu Z; Zhang X; Li Q; Jiang F
    IUBMB Life; 2020 Sep; 72(9):1960-1975. PubMed ID: 32726517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer.
    Zeng Q; Liu J; Wu Q; Song R; Miao W; Ma Y; Yang H
    Cancer Biother Radiopharm; 2024 May; 39(4):291-305. PubMed ID: 36094409
    [No Abstract]   [Full Text] [Related]  

  • 12. hsa-miR-135a-1 inhibits prostate cancer cell growth and migration by targeting EGFR.
    Xu B; Tao T; Wang Y; Fang F; Huang Y; Chen S; Zhu W; Chen M
    Tumour Biol; 2016 Oct; 37(10):14141-14151. PubMed ID: 27524492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
    Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
    Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑198 suppresses prostate tumorigenesis by targeting MIB1.
    Ray J; Hoey C; Huang X; Jeon J; Taeb S; Downes MR; Boutros PC; Liu SK
    Oncol Rep; 2019 Sep; 42(3):1047-1056. PubMed ID: 31322262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circHIPK3 modulates prostate cancer progression via targeting miR-448/MTDH signaling.
    Liu DC; Song LL; Li XZ; Liang Q; Zhang ZG; Han CH
    Clin Transl Oncol; 2021 Dec; 23(12):2497-2506. PubMed ID: 34142340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
    Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.
    Li Q; Lu S; Li X; Hou G; Yan L; Zhang W; Qiao B
    Clin Transl Oncol; 2017 May; 19(5):562-570. PubMed ID: 27921232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
    Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
    Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.